Pharmaceutics product development scientists are at the forefront of creating new pharmaceutical formulations that meet both therapeutic goals and patient needs. Their primary responsibility is to design drug products that deliver active pharmaceutical ingredients effectively and safely. This involves selecting the right combination of excipients, optimizing dosage forms, and improving drug stability and bioavailability. They use a variety of formulation techniques to develop products such as tablets, capsules, injectables, and novel delivery systems like transdermal patches or nanoparticle-based carriers. By conducting extensive preformulation and formulation studies, these scientists ensure the drug’s effectiveness while minimizing side effects and maximizing patient compliance.
Moreover, pharmaceutics product development scientists play a critical role in the entire product lifecycle, from initial concept to commercial production. They collaborate with analytical scientists, regulatory experts, and manufacturing teams to ensure that products meet quality standards and regulatory requirements. Their work often includes performing stability testing, compatibility studies, and scale-up processes to ensure that laboratory formulations can be produced consistently on an industrial scale. With ongoing advancements in drug delivery technologies and personalized medicine, these scientists continue to innovate, developing safer, more effective pharmaceutical products that address complex medical challenges and improve global health outcomes. Their contributions are essential to bringing new and improved therapies to patients worldwide.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia